n-glycylalanine has been researched along with Disease Models, Animal in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bauer, PO; Bieniek, KF; Boylan, KB; Castanedes-Casey, M; Chew, J; Daughrity, LM; Desaro, P; Dickson, DW; Edbauer, D; Fryer, JD; Gendron, TF; Jansen-West, K; Johnston, A; Kurti, A; Lee, CW; Murray, ME; Overstreet, K; Perkerson, EA; Petrucelli, L; Prudencio, M; Rademakers, R; Rousseau, L; Sasaguri, H; Stankowski, JN; Stetler, C; Whitelaw, EC; Zhang, YJ | 1 |
1 other study(ies) available for n-glycylalanine and Disease Models, Animal
Article | Year |
---|---|
Neurodegeneration. C9ORF72 repeat expansions in mice cause TDP-43 pathology, neuronal loss, and behavioral deficits.
Topics: Amyotrophic Lateral Sclerosis; Animals; Antisocial Personality Disorder; C9orf72 Protein; Cerebral Cortex; Dependovirus; Dipeptides; Disease Models, Animal; DNA-Binding Proteins; Frontotemporal Dementia; Gene Transfer Techniques; HEK293 Cells; Humans; Mice; Proteins; Purkinje Cells; RNA, Nuclear | 2015 |